On the morning of April 6, shares of Samchundang Pharmaceutical Corporation rose by over 4% on the domestic stock market. This surge followed news that the CEO has withdrawn his plan to sell his shares.


As of 9:38 a.m. on the same day, Samchundang Pharmaceutical Corporation was trading at 676,500 won, up 4.40% from the previous trading day. This upward trend is attributed to CEO Jeon Inseok's announcement on the same day that he has withdrawn his plan to sell shares worth 250 billion won.

Samchundang Pharmaceutical Headquarters. Samchundang Pharmaceutical.

Samchundang Pharmaceutical Headquarters. Samchundang Pharmaceutical.

View original image

Previously, CEO Jeon had announced his plan to sell shares on March 24. However, following this announcement, there was controversy in the market over the structure of the deal, as well as suspicions of stock price manipulation. These factors led to a sharp decline in the share price of Samchundang Pharmaceutical Corporation, which had previously emerged as the largest company on the KOSDAQ by market capitalization. On April 6, the company stated that the reason for the withdrawal was that "due to market fluctuations, the share price changed by more than 30% compared to the final closing price before the date the transaction plan was reported."



Later in the afternoon, CEO Jeon is scheduled to hold a press conference at the company's headquarters, where he will explain in detail the process behind the cancellation of the share sale plan and share his vision for management.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing